Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’
暂无分享,去创建一个
Reshma Kassanjee | Daniela De Angelis | Marian Farah | Debra Hanson | Jan Phillipus Lourens Labuschagne | Oliver Laeyendecker | Stéphane Le Vu | Brian D. M. Tom | Rui Wang | Alex Welte | J. P. Labuschagne | B. Tom | O. Laeyendecker | D. De Angelis | R. Kassanjee | A. Welte | Rui Wang | Marian Farah | D. Hanson | S. Le Vu
[1] R. Byers,et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. , 2002, AIDS research and human retroviruses.
[2] Tanmoy Bhattacharya,et al. Modeling sequence evolution in acute HIV-1 infection. , 2009, Journal of theoretical biology.
[3] Connie Celum,et al. HIV incidence determination in the United States: a multiassay approach. , 2013, The Journal of infectious diseases.
[4] L Meyer,et al. Principles and uses of HIV incidence estimation from recent infection testing--a review. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] B. Branson,et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. , 2006, AIDS research and human retroviruses.
[6] Stephen W Lagakos,et al. Augmented Cross‐Sectional Prevalence Testing for Estimating HIV Incidence , 2010, Biometrics.
[7] A. Burchell,et al. Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters , 2003, International journal of STD & AIDS.
[8] B. Turnbull. The Empirical Distribution Function with Arbitrarily Grouped, Censored, and Truncated Data , 1976 .
[9] L Meyer,et al. Estimation of the Distribution of Infection Times Using Longitudinal Serological Markers of HIV: Implications for the Estimation of HIV Incidence , 2011, Biometrics.
[10] Till Bärnighausen,et al. A New General Biomarker-based Incidence Estimator , 2012, Epidemiology.
[11] Bernard Branson,et al. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. , 2011, AIDS research and human retroviruses.
[12] R Brookmeyer,et al. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.
[13] Barbara Suligoi,et al. Estimating the distribution of the window period for recent HIV infections: A comparison of statistical methods , 2010, Statistics in medicine.
[14] Ekkehard Kopp,et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay , 2008, AIDS.
[15] John N. Nkengasong,et al. Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies , 2012, PloS one.
[16] S. Owen,et al. Evaluation of a Multiplex Assay for Estimation of HIV-1 Incidence , 2013, PloS one.
[17] Till Bärnighausen,et al. Errors in ‘BED’-Derived Estimates of HIV Incidence Will Vary by Place, Time and Age , 2009, PloS one.
[18] David Wright,et al. HIV seroconverting donors delay their return: screening test implications , 2002, Transfusion.
[19] Oliver Laeyendecker,et al. Estimation of HIV incidence using multiple biomarkers. , 2013, American journal of epidemiology.
[20] Bertran Auvert,et al. Mixture models for calibrating the BED for HIV incidence testing. , 2014, Statistics in medicine.
[21] Debra Hanson,et al. Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation , 2012, Journal of Clinical Microbiology.
[22] Joseph Vyankandondera,et al. Dual Testing Algorithm of BED-CEIA and AxSYM Avidity Index Assays Performs Best in Identifying Recent HIV Infection in a Sample of Rwandan Sex Workers , 2011, PloS one.
[23] Alex Welte,et al. Workshop summary: Novel biomarkers for HIV incidence assay development. , 2012, AIDS research and human retroviruses.
[24] G A Satten,et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.
[25] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[26] John Hargrove,et al. How Should We Best Estimate the Mean Recency Duration for the BED Method? , 2012, PloS one.
[27] Gonzalo Domingo,et al. More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence Assays , 2011, PLoS medicine.
[28] Oliver Laeyendecker,et al. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay , 2014, AIDS.
[29] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[30] Alex Welte,et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. , 2010, AIDS.
[31] Reshma Kassanjee,et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository , 2014, AIDS.
[32] J. Parry,et al. Assays for the detection of recent infections with human immunodeficiency virus type 1. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[33] Oliver Laeyendecker,et al. Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. , 2010, Journal of HIV AIDS surveillance & epidemiology.
[34] Reshma Kassanjee,et al. Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes , 2015, PloS one.